LUX Assure
closedSpecializes in delivering robust, highly sensitive, and simple to use chemical monitoring technologies.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
£2.4m | Early VC | ||
Total Funding | 000k |
EUR | 2018 | 2020 | 2021 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 |
% EBITDA margin | (237 %) | - | - |
Profit | 0000 | 0000 | 0000 |
% profit margin | (284 %) | - | - |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
R&D % of revenue | 68 % | - | - |
Source: Company filings or news article, Dealroom estimates
Related Content
Established in Edinburgh, Scotland, in 2001 by Patrick Hickey, LUX Assure Limited operates as a specialized chemical monitoring technology company catering to the global oil and gas industry. The firm was founded to deliver robust, simple-to-use monitoring technologies for both onshore and offshore applications. Its business model centers on collaborating with operators and service companies to develop, test, and commercialize new technologies that address recognized industry problems. This involves identifying solutions, demonstrating proof-of-concept, and partnering for deployment. The company draws on expertise from the life sciences, primarily utilizing light-based methods to create rapid, on-site monitoring products aimed at reducing overall operating costs.
LUX Assure provides technologies and services to monitor difficult-to-detect chemicals, such as corrosion and hydrate inhibitors, which are critical for maintaining the integrity of oilfield assets. Its client base consists of oil and gas operators and the associated supply chain. Revenue is generated through the provision of these specialized monitoring solutions and services. In 2013, the company secured a significant £3.25 million investment to shift its focus from a research and development entity to a direct service provider for the industry. Further funding rounds, including a £2.4 million investment in 2016 from notable backers like Chevron Technology Ventures and Statoil Technology Invest, have supported its growth and international expansion.
The company's product portfolio includes two main technologies: CoMic™ and OMMICA™. CoMic™ is an on-site deployable tool for managing corrosion by detecting corrosion inhibitor micelles, which serve as a marker for optimal dosage. This helps prevent both under-dosing, which risks corrosive attacks, and over-dosing, which can be costly and cause production issues. Originally requiring company specialists for on-site testing, CoMic™ was redeveloped in 2017 to be deployable by clients' on-site personnel, reducing costs and logistical hurdles. OMMICA™ is a colorimetric test kit used to determine the concentration of thermodynamic hydrate inhibitors, specifically monoethylene glycol (MEG) and methanol, in water, crude oil, and condensate. The company also developed MOTEYE™, a tool to simplify the analysis of components in produced water intended for reinjection, thereby improving enhanced oil recovery processes.
Keywords: chemical monitoring, oil and gas, corrosion management, asset integrity, hydrate inhibitors, offshore technology, onshore technology, CoMic, OMMICA, production chemicals, corrosion inhibitor, monoethylene glycol monitoring, methanol detection, produced water analysis, petroleum support, oilfield services, chemical optimisation, light-based monitoring, on-site testing, energy technology